Eucyte

EUCYT Laboratories was a private U.S. regenerative medicine company based in Las Vegas, Nevada that marketed and manufactured products derived from umbilical cord blood, umbilical cord, amniotic fluid, and exosomes. Publicly identified products included VidaCord, VidaGel, VidaStem, XOsomes, and VidaFlo. The company appears to have operated more as a commercial regenerative-products supplier than as a conventional clinical-stage biotech with a disclosed drug pipeline. FDA issued a warning letter in June 2020 regarding the company’s manufacture and marketing of these human cell and tissue-derived products, and later public business records indicate the company was revoked in Nevada and entered bankruptcy proceedings. Based on available evidence, the entity is not an exact match to the queried name "Eucyte," but EUCYT Laboratories is the closest likely healthcare-related company match.